220 related articles for article (PubMed ID: 15853691)
21. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent.
Yılmaz H; Sanlıer SH
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):69-77. PubMed ID: 23305120
[TBL] [Abstract][Full Text] [Related]
22. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles.
Zhang Y; Zhuo RX
Biomaterials; 2005 May; 26(14):2089-94. PubMed ID: 15576183
[TBL] [Abstract][Full Text] [Related]
24. Gelatin modified lipid nanoparticles for anti- viral drug delivery.
K S J; S S; Kalarikkal N; Pothen LA; Thomas S
Chem Phys Lipids; 2017 Oct; 207(Pt A):24-37. PubMed ID: 28698149
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
26. Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles.
Saxena A; Sachin K; Bohidar HB; Verma AK
Colloids Surf B Biointerfaces; 2005 Sep; 45(1):42-8. PubMed ID: 16112559
[TBL] [Abstract][Full Text] [Related]
27. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
29. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
30. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
[TBL] [Abstract][Full Text] [Related]
31. Polymeric micelles for pH-responsive delivery of cisplatin.
Shahin M; Safaei-Nikouei N; Lavasanifar A
J Drug Target; 2014 Aug; 22(7):629-37. PubMed ID: 24878378
[TBL] [Abstract][Full Text] [Related]
32. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
33. Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine.
Khan H; Shukla RN; Bajpai AK
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():457-65. PubMed ID: 26838872
[TBL] [Abstract][Full Text] [Related]
34. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
37. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
[TBL] [Abstract][Full Text] [Related]
38. Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery.
Madhusudana Rao K; Krishna Rao KS; Ramanjaneyulu G; Ha CS
Int J Pharm; 2015 Jan; 478(2):788-95. PubMed ID: 25528297
[TBL] [Abstract][Full Text] [Related]
39. Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.
Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Jaji AZ; Isa T; Mahmood SK; Zakaria MZAB
Pharm Res; 2017 Jun; 34(6):1193-1203. PubMed ID: 28382563
[TBL] [Abstract][Full Text] [Related]
40. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
